483
Ashland Specialty Ingredients, G.P.FDA 483 - Ashland Specialty Ingredients, G.P. - February 17, 2023
Record Details
An FDA inspection of Ashland Specialty Ingredients, G.P. in Bridgewater, NJ, revealed a significant quality system deficiency. The firm failed to revalidate a manufacturing process after implementing a new film inspection step for its GAFCHROMICTM EBT3 film, neglecting to document the evaluation or validation of this critical change. This indicates a breakdown in change control and process validation procedures.
- Person
Open in Dashboard
ID · 989c7c0b-87a1-49a7-bd2e-c2dda3363b3d